✦ LIBER ✦
Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple Myeloma
✍ Scribed by Britta Auel; Hartmut Goldschmidt; Thomas Geer; Thomas M. Moehler; Uwe Platzbecker; Ralph Naumann; Igor Blau; Mathias Hänel; Wolfgang Knauf; Holger Nückel; Hans-Jürgen Salwender; Christof Scheid; Katja Weisel; Marcus Gorschlüter; Axel Glasmacher; Ingo G. H. Schmidt-Wolf; The German Refractory Myeloma Study Group
- Book ID
- 113101178
- Publisher
- Springer-Verlag
- Year
- 2011
- Tongue
- English
- Weight
- 336 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0971-4502
No coin nor oath required. For personal study only.